<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1234" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1234/" /><meta name="ncbi_pagename" content="Canavan Disease - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Canavan Disease - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Canavan Disease" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/09/13" /><meta name="citation_author" content="Reuben Matalon" /><meta name="citation_author" content="Lisvania Delgado" /><meta name="citation_author" content="Kimberlee Michals-Matalon" /><meta name="citation_pmid" content="20301412" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1234/" /><meta name="citation_keywords" content="ASPA Deficiency" /><meta name="citation_keywords" content="Aspartoacylase Deficiency" /><meta name="citation_keywords" content="Aspartoacylase Deficiency" /><meta name="citation_keywords" content="ASPA Deficiency" /><meta name="citation_keywords" content="Aspartoacylase" /><meta name="citation_keywords" content="ASPA" /><meta name="citation_keywords" content="Canavan Disease" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Canavan Disease" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Reuben Matalon" /><meta name="DC.Contributor" content="Lisvania Delgado" /><meta name="DC.Contributor" content="Kimberlee Michals-Matalon" /><meta name="DC.Date" content="2018/09/13" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1234/" /><meta name="description" content="Most individuals with Canavan disease have the neonatal/infantile form. Although such infants appear normal early in life, by age three to five months, hypotonia, head lag, macrocephaly, and developmental delays become apparent. With age, children with neonatal/infantile-onset Canavan disease often become irritable and experience sleep disturbance, seizures, and feeding difficulties. Swallowing deteriorates, and some children require nasogastric feeding or permanent feeding gastrostomies. Joint stiffness increases, so that these children resemble individuals with cerebral palsy. Children with mild/juvenile Canavan disease may have normal or mildly delayed speech or motor development early in life without regression. In spite of developmental delay most of these children can be educated in typical classroom settings and may benefit from speech therapy or tutoring as needed. Most children with mild forms of Canavan disease have normal head size, although macrocephaly, retinitis pigmentosa, and seizures have been reported in a few individuals." /><meta name="og:title" content="Canavan Disease" /><meta name="og:type" content="book" /><meta name="og:description" content="Most individuals with Canavan disease have the neonatal/infantile form. Although such infants appear normal early in life, by age three to five months, hypotonia, head lag, macrocephaly, and developmental delays become apparent. With age, children with neonatal/infantile-onset Canavan disease often become irritable and experience sleep disturbance, seizures, and feeding difficulties. Swallowing deteriorates, and some children require nasogastric feeding or permanent feeding gastrostomies. Joint stiffness increases, so that these children resemble individuals with cerebral palsy. Children with mild/juvenile Canavan disease may have normal or mildly delayed speech or motor development early in life without regression. In spite of developmental delay most of these children can be educated in typical classroom settings and may benefit from speech therapy or tutoring as needed. Most children with mild forms of Canavan disease have normal head size, although macrocephaly, retinitis pigmentosa, and seizures have been reported in a few individuals." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1234/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/canavan/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1234/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8A406BE0409161000000000170007E.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1234_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1234_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ced/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cantu/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1234_"><span class="title" itemprop="name">Canavan Disease</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: ASPA Deficiency, Aspartoacylase Deficiency</div><p class="contrib-group"><span itemprop="author">Reuben Matalon</span>, MD, PhD, <span itemprop="author">Lisvania Delgado</span>, BS, and <span itemprop="author">Kimberlee Michals-Matalon</span>, PhD, RD.</p><a data-jig="ncbitoggler" href="#__NBK1234_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1234_ai__"><div class="contrib half_rhythm"><span itemprop="author">Reuben Matalon</span>, MD, PhD<div class="affiliation small">Departments of Pediatrics and Biochemistry and Molecular Biology<br />University of Texas Medical Branch<br />Galveston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.bmtu@nolatamr" class="oemail">ude.bmtu@nolatamr</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Lisvania Delgado</span>, BS<div class="affiliation small">Departments of Pediatrics and Biochemistry and Molecular Biology<br />University of Texas Medical Branch<br />Galveston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.bmtu@dagledil" class="oemail">ude.bmtu@dagledil</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Kimberlee Michals-Matalon</span>, PhD, RD<div class="affiliation small">Department of Health and Human Performance<br />University of Houston<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.hu@nolatamk" class="oemail">ude.hu@nolatamk</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">September 16, 1999</span>; Last Update: <span itemprop="dateModified">September 13, 2018</span>.</p><p><em>Estimated reading time: 16 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="canavan.Summary" itemprop="description"><h2 id="_canavan_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Most individuals with Canavan disease have the neonatal/infantile form. Although such infants appear normal early in life, by age three to five months, hypotonia, head lag, macrocephaly, and developmental delays become apparent. With age, children with neonatal/infantile-onset Canavan disease often become irritable and experience sleep disturbance, seizures, and feeding difficulties. Swallowing deteriorates, and some children require nasogastric feeding or permanent feeding gastrostomies. Joint stiffness increases, so that these children resemble individuals with cerebral palsy. Children with mild/juvenile Canavan disease may have normal or mildly delayed speech or motor development early in life without regression. In spite of developmental delay most of these children can be educated in typical classroom settings and may benefit from speech therapy or tutoring as needed. Most children with mild forms of Canavan disease have normal head size, although macrocephaly, retinitis pigmentosa, and seizures have been reported in a few individuals.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of Canavan disease is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical findings and elevated N-acetylaspartic acid (NAA) in urine and/or with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ASPA</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i></p><ul><li class="half_rhythm"><div>Neonatal/infantile Canavan disease. Treatment is supportive and directed to providing adequate nutrition and hydration, managing infectious diseases, and protecting the airway. Hospice care is a resource used by the families of the individuals <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> by the disease. Physical therapy minimizes contractures and maximizes motor abilities and seating posture; special education programs enhance communication skills. Seizures are treated with antiepileptic drugs. Gastrostomy may be needed to maintain adequate food intake and hydration when swallowing difficulties exist.</div></li><li class="half_rhythm"><div>Mild/juvenile Canavan disease. May require speech therapy or tutoring but no special medical care.</div></li></ul><p><i>Surveillance:</i></p><ul><li class="half_rhythm"><div>Neonatal/infantile Canavan disease. Follow up every six months to evaluate developmental status and evidence of any new problems.</div></li><li class="half_rhythm"><div>Mild/juvenile Canavan disease. Annual routine follow up by a pediatric neurologist or a developmental pediatrician is indicated.</div></li></ul></div><div><h4 class="inline">Genetic counseling.</h4><p>Canavan disease is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Each pregnancy of a couple in which both partners are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ASPA</i> has a 25% chance of resulting in a child with Canavan disease, a 50% chance of resulting in a child who is an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of resulting in a child who is unaffected and not a carrier. Carrier testing is available on a population basis for individuals of <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> heritage. Carrier testing for at-risk relatives, prenatal testing for pregnancies at increased risk, and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible when the pathogenic variants in the family are known.</p></div></div><div id="canavan.Diagnosis"><h2 id="_canavan_Diagnosis_">Diagnosis</h2><div id="canavan.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Canavan disease <b>should be suspected</b> in individuals with</p><ul><li class="half_rhythm"><div>The triad of hypotonia, head lag, and macrocephaly after age three to five months</div></li><li class="half_rhythm"><div>Poor visual following and difficulties with suck and swallow</div></li><li class="half_rhythm"><div>Developmental delays (with regression in infantile form and without regression in mild/juvenile form)</div></li><li class="half_rhythm"><div>Leukodystrophy on neuroimaging (generalized in infantile form and localized to basal ganglia in mild/juvenile form)</div></li><li class="half_rhythm"><div>Elevated N-acetylaspartic acid (NAA) in urine using gas chromatography-mass spectrometry (GC-MS)</div></li></ul></div><div id="canavan.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of Canavan disease <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical findings and elevated N-acetylaspartic acid (NAA) in urine using gas chromatography-mass spectrometry (see Note) and/or <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ASPA</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1234/table/canavan.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figcanavanTmoleculargenetictestingused" rid-ob="figobcanavanTmoleculargenetictestingused">Table 1</a>).</p><p>Note: (1) Although NAA concentration is also elevated in the blood and cerebrospinal fluid (CSF) of children with neonatal/infantile (severe) Canavan disease, elevated concentration of NAA in urine is sufficient for diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#canavan.REF.michals.2011">Michals &#x00026; Matalon 2011</a>]. (2) Canavan disease is associated with decreased aspartoacylase enzyme activity; individuals with severe Canavan disease may have unmeasurable enzyme activity, and carriers (heterozygotes) may have enzyme activity ~50% of normal. Aspartoacylase enzyme activity may not be reliable in the diagnosis of Canavan disease because enzyme activity fluctuates with culture conditions; therefore, measurement of the urinary concentration of NAA is the preferred diagnostic method [<a class="bk_pop" href="#canavan.REF.matalon.1993.744">Matalon et al 1993</a>].</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of Canavan disease is broad, infants with the distinctive findings described in <a href="#canavan.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#canavan.Option_1">Option 1</a>), whereas those with a mild/juvenile Canavan disease phenotype indistinguishable from many other inherited disorders with developmental delay are more likely to be diagnosed using genomic testing (see <a href="#canavan.Option_2">Option 2</a>).</p><div id="canavan.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of Canavan disease, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>.</p><p><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>ASPA</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</p><p>Targeted analysis for the pathogenic variants <a class="figpopup" href="/books/NBK1234/table/canavan.T.selected_aspa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figcanavanTselectedaspapathogenicvaria" rid-ob="figobcanavanTselectedaspapathogenicvaria">p.Glu285Ala</a>, <a class="figpopup" href="/books/NBK1234/table/canavan.T.selected_aspa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figcanavanTselectedaspapathogenicvaria" rid-ob="figobcanavanTselectedaspapathogenicvaria">p.Tyr231Ter</a>, and <a class="figpopup" href="/books/NBK1234/table/canavan.T.selected_aspa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figcanavanTselectedaspapathogenicvaria" rid-ob="figobcanavanTselectedaspapathogenicvaria">p.Ala305Glu</a> can be performed first in individuals of <b><a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a></b> ancestry.</p><p>Targeted analysis for the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1234/table/canavan.T.selected_aspa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figcanavanTselectedaspapathogenicvaria" rid-ob="figobcanavanTselectedaspapathogenicvaria">p.Ala305Glu</a> can be performed first in individuals of <b>non-<a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a></b> ancestry.</p><p>Note: This targeted testing is most appropriate when (1) biochemical testing indicates a diagnosis of Canavan disease or (2) the individual is of <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> ancestry.</p><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>ASPA</i> and other genes of interest (see <a href="#canavan.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK1234/table/canavan.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figcanavanTmoleculargenetictestingused" rid-ob="figobcanavanTmoleculargenetictestingused">Table 1</a>).</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p>Note: Follow-up urinary NAA or enzyme testing may help to interpret sequencing results if a variant of <a class="def" href="/books/n/gene/glossary/def-item/unknown-significance/">unknown significance</a> is identified.</p></div><div id="canavan.Option_2"><h4>Option 2</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from many other inherited disorders characterized by developmental delay, <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p><b>Exome array</b> (when clinically available) may be considered if <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is non-diagnostic.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="canavan.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Canavan Disease</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1234/table/canavan.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__canavan.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_canavan.T.molecular_genetic_testing_used_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_canavan.T.molecular_genetic_testing_used_1_1_1_2" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_canavan.T.molecular_genetic_testing_used_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_canavan.T.molecular_genetic_testing_used_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>ASPA</i></td><td headers="hd_h_canavan.T.molecular_genetic_testing_used_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Targeted testing&#x000a0;<sup>3</sup></td><td headers="hd_h_canavan.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1234/table/canavan.T.selected_aspa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figcanavanTselectedaspapathogenicvaria" rid-ob="figobcanavanTselectedaspapathogenicvaria">p.Glu285Ala</a>, <a class="figpopup" href="/books/NBK1234/table/canavan.T.selected_aspa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figcanavanTselectedaspapathogenicvaria" rid-ob="figobcanavanTselectedaspapathogenicvaria">p.Tyr231Ter</a></td><td headers="hd_h_canavan.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a>: 98%&#x000a0;<sup>4</sup><br />Non-<a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a>: 3%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_canavan.T.molecular_genetic_testing_used_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1234/table/canavan.T.selected_aspa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figcanavanTselectedaspapathogenicvaria" rid-ob="figobcanavanTselectedaspapathogenicvaria">p.Ala305Glu</a></td><td headers="hd_h_canavan.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a>: 1%&#x000a0;<sup>5</sup><br />Non-<a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a>: 30%-60%&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_canavan.T.molecular_genetic_testing_used_1_1_1_2" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>6</sup></td><td headers="hd_h_canavan.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~99%&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_canavan.T.molecular_genetic_testing_used_1_1_1_2" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>8</sup></td><td headers="hd_h_canavan.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9 reported&#x000a0;<sup>9</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="canavan.TF.1.1"><p class="no_margin">See <a href="/books/NBK1234/#canavan.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="canavan.TF.1.2"><p class="no_margin">See <a href="#canavan.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="canavan.TF.1.3"><p class="no_margin">Various molecular methods may be used to detect targeted variants.</p></div></dd><dt>4. </dt><dd><div id="canavan.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#canavan.REF.michals.2011">Michals &#x00026; Matalon [2011]</a></p></div></dd><dt>5. </dt><dd><div id="canavan.TF.1.5"><p class="no_margin"><a class="bk_pop" href="#canavan.REF.kaul.1994b.34">Kaul et al [1994b]</a>, <a class="bk_pop" href="#canavan.REF.elpeleg.1999.531">Elpeleg &#x00026; Shaag [1999]</a></p></div></dd><dt>6. </dt><dd><div id="canavan.TF.1.6"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>7. </dt><dd><div id="canavan.TF.1.7"><p class="no_margin"><a class="bk_pop" href="#canavan.REF.kaul.1994b.34">Kaul et al [1994b]</a>, <a class="bk_pop" href="#canavan.REF.elpeleg.1999.531">Elpeleg &#x00026; Shaag [1999]</a>, <a class="bk_pop" href="#canavan.REF.olsen.2002.e55">Olsen et al [2002]</a>, <a class="bk_pop" href="#canavan.REF.zeng.2002.557">Zeng et al [2002]</a>, <a class="bk_pop" href="#canavan.REF.michals.2011">Michals &#x00026; Matalon [2011]</a></p></div></dd><dt>8. </dt><dd><div id="canavan.TF.1.8"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods that may be used include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>9. </dt><dd><div id="canavan.TF.1.9"><p class="no_margin"><a class="bk_pop" href="#canavan.REF.shaag.1995.572">Shaag et al [1995]</a>, <a class="bk_pop" href="#canavan.REF.elpeleg.1999.531">Elpeleg &#x00026; Shaag [1999]</a>, <a class="bk_pop" href="#canavan.REF.zeng.2006.156">Zeng et al [2006]</a>, <a class="bk_pop" href="#canavan.REF.caliebe.2010.184">Caliebe et al [2010]</a>, <a class="bk_pop" href="#canavan.REF.cozzolino.2011.706">Cozzolino et al [2011]</a></p></div></dd></dl></div></div></div></div></div></div><div id="canavan.Clinical_Characteristics"><h2 id="_canavan_Clinical_Characteristics_">Clinical Characteristics</h2><div id="canavan.Clinical_Description"><h3>Clinical Description</h3><p>Canavan disease is a neurodegenerative disorder associated with spongy degeneration of the white matter of the brain. Typical presentation is in the first several months of life, although a later presentation is also recognized.</p><div id="canavan.NeonatalInfantile_Severe_Canavan"><h4>Neonatal/Infantile (Severe) Canavan Disease</h4><p><b>Presentation.</b> Most individuals with Canavan disease have the neonatal/infantile form. Such infants appear normal early in life, but by age three to five months, hypotonia, head lag, macrocephaly, and developmental delays become apparent.</p><p><b>Hypotonia</b> is an early finding associated with poor head control.</p><ul><li class="half_rhythm"><div>Inability to support the head is a constant feature of this disorder.</div></li><li class="half_rhythm"><div>With age, hypotonia gives way to spasticity.</div></li></ul><p><b>Macrocephaly.</b> In early infancy the head circumference may be normal or in some cases remain at the upper limit of normal. However, in the majority of individuals, the head circumference increases after age six months and by the first year is above the 90th percentile.</p><p><b>Developmental delay</b> becomes more obvious with increasing age:</p><ul><li class="half_rhythm"><div>Children are especially delayed in their motor skills and are not able to sit, stand, walk, or talk.</div></li><li class="half_rhythm"><div>They learn to interact socially, laugh and smile, reach for objects, and raise their heads in the prone position.</div></li></ul><p><b>Vision and hearing.</b> Early in life there is a decreased ability to fix and follow. Optic atrophy usually develops in the second year of life. Hearing is usually not impaired.</p><p><b>Progression.</b> With age, children with neonatal/infantile-onset Canavan disease often become irritable and experience sleep disturbance, seizures, and feeding difficulties. Swallowing deteriorates, and some of the children require nasogastric feeding or permanent feeding gastrostomies. Joint stiffness increases, so that these children resemble individuals with cerebral palsy.</p><p><b>Prognosis.</b> Most individuals with Canavan disease die in the first decade of life. However, with improved medical and nursing care a larger number of children survive beyond the first decade.</p></div><div id="canavan.MildJuvenile_Canavan_Disease"><h4>Mild/Juvenile Canavan Disease</h4><p><b>Presentation.</b> Children with mild/juvenile Canavan disease may have normal or mildly delayed speech or motor development early in life without regression. In spite of developmental delay most of these children can be educated in typical classroom settings and may benefit from speech therapy or tutoring as needed [<a class="bk_pop" href="#canavan.REF.matalon.2015">Matalon &#x00026; Michals Matalon 2015</a>]. Most of the children with mild forms of Canavan disease have normal head size, although macrocephaly, retinitis pigmentosa, and seizures have been reported in a few individuals [<a class="bk_pop" href="#canavan.REF.tacke.2005.252">Tacke et al 2005</a>, <a class="bk_pop" href="#canavan.REF.delaney.2015.218">Delaney et al 2015</a>].</p></div><div id="canavan.Neuroimaging"><h4>Neuroimaging</h4><p><b>Neonatal/infantile (severe) Canavan disease.</b> CT or MRI performed in infancy may be interpreted as normal [<a class="bk_pop" href="#canavan.REF.matalon.2000.d307">Matalon &#x00026; Michals-Matalon 2000</a>]. Diffuse, symmetric white matter changes are observed in the subcortical areas and in the cerebral cortex; involvement of the cerebellum and brain stem is less marked [<a class="bk_pop" href="#canavan.REF.matalon.1995.511">Matalon et al 1995</a>].</p><p>Magnetic resonance spectrometry (MRS) to detect N-acetylaspartic acid has been reported as the best method for the diagnosis of Canavan disease in infants, even with normal serum and urine N-acetylaspartic acid levels [<a class="bk_pop" href="#canavan.REF.karimzadeh.2014.66">Karimzadeh et al 2014</a>].</p><p><b>Mild/juvenile Canavan disease.</b> Brain MRI does not show general white matter changes, although increased signal intensities in the basal ganglia have been reported [<a class="bk_pop" href="#canavan.REF.surendran.2003.809">Surendran et al 2003</a>, <a class="bk_pop" href="#canavan.REF.yalcinkaya.2005.336">Yalcinkaya et al 2005</a>, <a class="bk_pop" href="#canavan.REF.michals.2011">Michals &#x00026; Matalon 2011</a>].</p></div><div id="canavan.Neuropathology"><h4>Neuropathology</h4><p>In neonatal/infantile Canavan disease subcortical spongy degeneration is observed. Electron microscopy (EM) reveals swollen astrocytes and distorted mitochondria.</p></div></div><div id="canavan.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Neonatal/infantile (severe) Canavan disease is associated with complete loss of ASPA enzyme activity. The common <a class="figpopup" href="/books/NBK1234/table/canavan.T.selected_aspa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figcanavanTselectedaspapathogenicvaria" rid-ob="figobcanavanTselectedaspapathogenicvaria">p.Tyr231Ter</a>, <a class="figpopup" href="/books/NBK1234/table/canavan.T.selected_aspa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figcanavanTselectedaspapathogenicvaria" rid-ob="figobcanavanTselectedaspapathogenicvaria">p.Glu285Ala</a>, and <a class="figpopup" href="/books/NBK1234/table/canavan.T.selected_aspa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figcanavanTselectedaspapathogenicvaria" rid-ob="figobcanavanTselectedaspapathogenicvaria">p.Ala305Glu</a> pathogenic variants in the <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> (with each other) state are associated with neonatal/infantile disease [<a class="bk_pop" href="#canavan.REF.matalon.1998.69">Matalon &#x00026; Michals-Matalon 1998</a>].</p><p>Mild/juvenile Canavan disease is associated with at least one "mild" <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (<a class="figpopup" href="/books/NBK1234/table/canavan.T.selected_aspa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figcanavanTselectedaspapathogenicvaria" rid-ob="figobcanavanTselectedaspapathogenicvaria">p.Tyr288Cys</a>, <a class="figpopup" href="/books/NBK1234/table/canavan.T.selected_aspa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figcanavanTselectedaspapathogenicvaria" rid-ob="figobcanavanTselectedaspapathogenicvaria">p.Arg71His</a>, or <a class="figpopup" href="/books/NBK1234/table/canavan.T.selected_aspa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figcanavanTselectedaspapathogenicvaria" rid-ob="figobcanavanTselectedaspapathogenicvaria">p.Pro257Arg</a>) with residual ASPA enzyme activity. Individuals are usually <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> with one mild variant and one severe variant [<a class="bk_pop" href="#canavan.REF.surendran.2003.809">Surendran et al 2003</a>, <a class="bk_pop" href="#canavan.REF.yalcinkaya.2005.336">Yalcinkaya et al 2005</a>, <a class="bk_pop" href="#canavan.REF.kurczynski.2011">Kurczynski &#x00026; Victorio 2011</a>, <a class="bk_pop" href="#canavan.REF.michals.2011">Michals &#x00026; Matalon 2011</a>].</p></div><div id="canavan.Nomenclature"><h3>Nomenclature</h3><p>Other names for neonatal/infantile (severe) Canavan disease that are no longer in use:</p><ul><li class="half_rhythm"><div>Spongy degeneration of the brain (see also <a href="#canavan.Differential_Diagnosis">Differential Diagnosis</a>)</div></li><li class="half_rhythm"><div>Van Bogaert and Bertrand disease</div></li></ul></div><div id="canavan.Prevalence"><h3>Prevalence</h3><p>While Canavan disease occurs in all ethnic groups, most reported individuals are of <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> origin.</p><p>Carrier frequency has varied from 1:40 to 1:82 in the <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> population depending on the source of samples [<a class="bk_pop" href="#canavan.REF.kronn.1995.1250">Kronn et al 1995</a>, <a class="bk_pop" href="#canavan.REF.matalon.1995.511">Matalon et al 1995</a>, <a class="bk_pop" href="#canavan.REF.fares.2008.236">Fares et al 2008</a>].</p><p>The <a class="def" href="/books/n/gene/glossary/def-item/carrier-rate/">carrier rate</a> in non-Jews is not known; however, it is assumed to be much lower than the carrier rate in the <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> population.</p></div></div><div id="canavan.Genetically_Related_Allelic_Diso"><h2 id="_canavan_Genetically_Related_Allelic_Diso_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>ASPA</i>.</p></div><div id="canavan.Differential_Diagnosis"><h2 id="_canavan_Differential_Diagnosis_">Differential Diagnosis</h2><div id="canavan.T.disorders_to_consider_in_the_d" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of Canavan Disease</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1234/table/canavan.T.disorders_to_consider_in_the_d/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__canavan.T.disorders_to_consider_in_the_d_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Features of This Disorder</th></tr><tr><th headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_4" id="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/Canavan disease</th><th headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_4" id="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from Canavan disease</th></tr></thead><tbody><tr><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/alexander/">Alexander disease</a></td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GFAP</i></td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neurodegenerative disorder of infancy</div></li><li class="half_rhythm"><div>Normal or large head</div></li></ul></td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Marked frontal predominance of white matter changes</div></li><li class="half_rhythm"><div>Rostrocaudal progression of myelin loss on serial imaging studies</div></li></ul></td></tr><tr><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/tay-sachs/">Tay-Sachs disease</a></td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HEXA</i></td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neurodegenerative disorder of infancy</div></li><li class="half_rhythm"><div>Normal or large head</div></li></ul></td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Increased startle response</div></li><li class="half_rhythm"><div>Cherry-red spot of the macula of the retina</div></li></ul></td></tr><tr><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mld/">Metachromatic leukodystrophy</a></td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ARSA</i></td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neurodegenerative disorder of infancy</div></li><li class="half_rhythm"><div>Normal or large head</div></li></ul></td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Late-infantile onset (age &#x0003c;30 mos) after a period of apparently normal development</td></tr><tr><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Glutaric acidemia type 1<br />(OMIM <a href="https://omim.org/entry/231670" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">231670</a>)</td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GCDH</i></td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neurodegenerative disorder of infancy</div></li><li class="half_rhythm"><div>Normal or large head</div></li></ul></td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Progressive movement disorder</td></tr><tr><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/narp/">Leigh syndrome</a><br />(see also <a href="/books/n/gene/mt-overview/">Mitochondrial Disorders Overview</a>)</td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">mtDNA</td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">mt<br />AR</td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spongy degeneration of the brain</td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Decompensation (often w/elevated lactate levels in blood &#x00026;/or CSF) during an intercurrent illness is typically associated w/psychomotor retardation or regression.</td></tr><tr><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/nkh/">Glycine encephalopathy</a> (nonketotic hyperglycinemia)</td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AMT</i><br /><i>GCSH</i><br /><i>GLDC</i></td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spongy degeneration of the brain</td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neonatal form manifests in1st hrs/days of life w/progressive lethargy, hypotonia, &#x00026; myoclonic jerks.</div></li><li class="half_rhythm"><div>Apnea</div></li><li class="half_rhythm"><div>Profound intellectual disability</div></li><li class="half_rhythm"><div>Intractable seizures</div></li></ul></td></tr><tr><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Viral encephalitis</td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spongy degeneration of the brain</td><td headers="hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_canavan.T.disorders_to_consider_in_the_d_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">History of viral infection in a previously typical individual</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a></p></div></dd><dt></dt><dd><div><p class="no_margin">AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a></p></div></dd><dt></dt><dd><div><p class="no_margin">XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt></dt><dd><div><p class="no_margin">mt = mitochondrial</p></div></dd><dt></dt><dd><div><p class="no_margin">NA = not applicable</p></div></dd></dl></div></div></div><p>Mild/juvenile Canavan disease may be misdiagnosed as a mitochondrial disorder (see <a href="/books/n/gene/mt-overview/">Mitochondrial Disorders Overview</a>).</p></div><div id="canavan.Management"><h2 id="_canavan_Management_">Management</h2><div id="canavan.Evaluations_Following_Initial_Di"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease in an individual diagnosed with Canavan disease, the following evaluations are recommended if they have not already been completed.</p><p><b>Neonatal/infantile (severe) form</b></p><ul><li class="half_rhythm"><div>Brain MRI and MRI spectroscopy</div></li><li class="half_rhythm"><div>Neurologic evaluation</div></li><li class="half_rhythm"><div>Developmental assessment</div></li><li class="half_rhythm"><div>Ophthalmologic assessment</div></li><li class="half_rhythm"><div>Nutritional assessment</div></li></ul><p><b>Juvenile/mild form</b></p><ul><li class="half_rhythm"><div>Neurologic evaluation</div></li><li class="half_rhythm"><div>Developmental assessment</div></li><li class="half_rhythm"><div>Ophthalmologic assessment</div></li></ul><p><b>All Canavan disease.</b> Consultation with a clinical geneticist and/or genetic counselor</p></div><div id="canavan.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Neonatal/infantile Canavan disease</b></p><ul><li class="half_rhythm"><div>Treatment is supportive and directed to providing adequate nutrition and hydration, managing infectious diseases, and protecting the airway.</div></li><li class="half_rhythm"><div>Hospice care is a resource used by the families of the individuals <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> by the disease.</div></li><li class="half_rhythm"><div>Children benefit from:</div><ul><li class="half_rhythm"><div>Physical therapy to minimize contractures and optimize abilities and seating posture,</div></li><li class="half_rhythm"><div>Other therapies to enhance communication skills (especially in those with a more gradual clinical course), and</div></li><li class="half_rhythm"><div>Early intervention and special education programs.</div></li></ul></li><li class="half_rhythm"><div>Seizures may be treated with antiepileptic drugs.</div></li><li class="half_rhythm"><div>A feeding gastrostomy may be required to maintain adequate intake and hydration in the presence of swallowing difficulties.</div></li><li class="half_rhythm"><div>Botox<sup>&#x000ae;</sup> injections may be used to relieve spasticity.</div></li></ul><p><b>Mild/juvenile Canavan disease.</b> Individuals may require speech therapy or tutoring but require no special medical care.</p></div><div id="canavan.Prevention_of_Secondary_Complica"><h3>Prevention of Secondary Complications</h3><p><b>Neonatal/infantile Canavan disease</b></p><ul><li class="half_rhythm"><div>Contractures and decubiti need to be prevented by exercise and position changes.</div></li><li class="half_rhythm"><div>Feeding difficulties and seizures increase the risk of aspiration, which can be reduced with use of a G-tube for feeding.</div></li></ul></div><div id="canavan.Surveillance"><h3>Surveillance</h3><p><b>Neonatal/infantile Canavan disease.</b> Follow up at six-month intervals by a pediatric neurologist to evaluate developmental status and evidence of any new problems is suggested.</p><p><b>Mild/juvenile Canavan disease.</b> Annual routine follow up by a pediatric neurologist (or a developmental pediatrician) is indicated.</p></div><div id="canavan.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#canavan.Related_Genetic_Counseling_Issue">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="canavan.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="canavan.Genetic_Counseling"><h2 id="_canavan_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="canavan.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Canavan disease is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="canavan.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>ASPA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is consistent within families.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> No severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> person has been known to reproduce. Individuals with mild/juvenile Canavan disease could reproduce; this has not been reported to date.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>ASPA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="canavan.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>ASPA</i> pathogenic variants in the family.</p><p>Carrier detection using biochemical assay is not routinely possible because it relies on a complex enzyme assay in cultured skin fibroblasts and enzyme activity fluctuates with culture conditions.</p></div><div id="canavan.Population_Screening"><h3>Population Screening</h3><p><b>Individuals of <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> heritage.</b> Because of the relatively increased <a class="def" href="/books/n/gene/glossary/def-item/carrier-rate/">carrier rate</a> in Ashkenazi Jews and the availability of <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a>, population screening has been initiated for Ashkenazi Jewish individuals of reproductive age in some states and is recommended in published guidelines [<a class="bk_pop" href="#canavan.REF.acog_committee_on_genetics.2009.950">ACOG Committee on Genetics 2009</a>]. Through this type of screening program, couples in which both partners are carriers can be made aware of their status and risks before having <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children. Then, through genetic counseling and the option of prenatal testing, such families can, if they choose, bring to term only those pregnancies in which the fetus is unaffected. In population screening of people of Ashkenazi Jewish heritage, a panel of the two or three common <i>ASPA</i> pathogenic variants (<a class="figpopup" href="/books/NBK1234/table/canavan.T.selected_aspa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figcanavanTselectedaspapathogenicvaria" rid-ob="figobcanavanTselectedaspapathogenicvaria">p.Glu285Ala</a>, <a class="figpopup" href="/books/NBK1234/table/canavan.T.selected_aspa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figcanavanTselectedaspapathogenicvaria" rid-ob="figobcanavanTselectedaspapathogenicvaria">p.Tyr231Ter</a>, and <a class="figpopup" href="/books/NBK1234/table/canavan.T.selected_aspa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figcanavanTselectedaspapathogenicvaria" rid-ob="figobcanavanTselectedaspapathogenicvaria">p.Ala305Glu</a>) can be expected to identify 99% of heterozygotes.</p><p><b>Assisted reproductive technologies.</b> Individuals who are pursuing reproductive technologies that involve gamete (egg or sperm) donation and who are at increased risk of being <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an <i>ASPA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> because of family history or ethnic background should be offered screening. If the gamete recipient is a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, potential gamete donors can be screened to determine carrier status.</p></div><div id="canavan.Related_Genetic_Counseling_Issue"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="canavan.Prenatal_Testing_and_Preimplanta"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>ASPA</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="canavan.Resources"><h2 id="_canavan_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Canavan Foundation</b></div><div>450 West End Avenue</div><div>#6A</div><div>New York NY 10024</div><div><b>Phone:</b> 877-422-6282 (toll free); 212-873-4640</div><div><b>Fax:</b> 212-873-7892</div><div><b>Email:</b> info@canavanfoundation.org</div><div><a href="http://www.canavanfoundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.canavanfoundation.org</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Canavan-Disease-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Canavan Disease Information Page</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="https://ghr.nlm.nih.gov/condition/canavan-disease" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Canavan Disease</a></div></li><li class="half_rhythm"><div><b>Center for Jewish Genetics</b></div><div>Ben Gurion Way</div><div>30 South Wells Street</div><div>Chicago IL 60606</div><div><b>Phone:</b> 312-357-4718</div><div><b>Email:</b> jewishgeneticsctr@juf.org</div><div><a href="http://www.jewishgenetics.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.jewishgenetics.org</a></div></li><li class="half_rhythm"><div><b>National Tay-Sachs and Allied Diseases Association, Inc. (NTSAD)</b></div><div>2001 Beacon Street</div><div>Suite 204</div><div>Boston MA 02135</div><div><b>Phone:</b> 800-906-8723 (toll-free)</div><div><b>Fax:</b> 617-277-0134</div><div><b>Email:</b> info@ntsad.org</div><div><a href="http://www.ntsad.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ntsad.org</a></div></li><li class="half_rhythm"><div><b>United Leukodystrophy Foundation (ULF)</b></div><div>224 North Second Street</div><div>Suite 2</div><div>DeKalb IL 60115</div><div><b>Phone:</b> 800-728-5483 (toll-free); 815-748-3211</div><div><b>Fax:</b> 815-748-0844</div><div><b>Email:</b> office@ulf.org</div><div><a href="http://www.ulf.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ulf.org</a></div></li><li class="half_rhythm"><div><b>Myelin Disorders Bioregistry Project</b></div><div><b>Email:</b> myelindisorders@cnmc.org</div><div><a href="https://www.chop.edu/research/myelin-disorders-biorepository-project" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Myelin Disorders Bioregistry Project</a></div></li></ul></div><div id="canavan.Molecular_Genetics"><h2 id="_canavan_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="canavan.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Canavan Disease: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1234/table/canavan.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__canavan.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_canavan.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_canavan.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_canavan.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_canavan.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_canavan.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_canavan.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_canavan.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/443" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ASPA</i></a></td><td headers="hd_b_canavan.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=443" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">17p13<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_canavan.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P45381" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Aspartoacylase</a></td><td headers="hd_b_canavan.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/ASPA" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ASPA @ LOVD</a></td><td headers="hd_b_canavan.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ASPA" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ASPA</a></td><td headers="hd_b_canavan.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ASPA[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ASPA</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="canavan.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="canavan.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Canavan Disease (<a href="/omim/271900,608034" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1234/table/canavan.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__canavan.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/271900" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">271900</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CANAVAN DISEASE</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608034" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608034</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ASPARTOACYLASE; ASPA</td></tr></tbody></table></div></div><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> comprises 29 kb with six exons and five introns. The exons vary in size from 94 bp (<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 3) to 514 bp (exon 6). For a detailed summary of gene and protein information, see, <a href="/books/NBK1234/#canavan.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> See <a class="figpopup" href="/books/NBK1234/table/canavan.T.selected_aspa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figcanavanTselectedaspapathogenicvaria" rid-ob="figobcanavanTselectedaspapathogenicvaria">Table 3</a>. The major pathogenic variants are p.Glu285Ala, p.Tyr231Ter, and p.Ala305Glu. (For more information, see <a href="/books/NBK1234/#canavan.molgen.TA">Table A</a>.)</p><p>Two pathogenic variants, <a class="figpopup" href="/books/NBK1234/table/canavan.T.selected_aspa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figcanavanTselectedaspapathogenicvaria" rid-ob="figobcanavanTselectedaspapathogenicvaria">p.Glu285Ala</a> and <a class="figpopup" href="/books/NBK1234/table/canavan.T.selected_aspa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figcanavanTselectedaspapathogenicvaria" rid-ob="figobcanavanTselectedaspapathogenicvaria">p.Tyr231Ter</a>, account for 98% of pathogenic variants in the <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> population and 3% of pathogenic variants in non-Ashkenazi Jewish populations [<a class="bk_pop" href="#canavan.REF.michals.2011">Michals &#x00026; Matalon 2011</a>].</p><p>One <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, <a class="figpopup" href="/books/NBK1234/table/canavan.T.selected_aspa_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figcanavanTselectedaspapathogenicvaria" rid-ob="figobcanavanTselectedaspapathogenicvaria">p.Ala305Glu</a>, accounts for 30%-60% of pathogenic variants in non-<a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> populations and approximately 1% of pathogenic variants in the Ashkenazi Jewish population [<a class="bk_pop" href="#canavan.REF.kaul.1994b.34">Kaul et al 1994b</a>, <a class="bk_pop" href="#canavan.REF.elpeleg.1999.531">Elpeleg &#x00026; Shaag 1999</a>].</p><p>Note that a <a class="figpopup" href="/books/NBK1234/table/canavan.T.disorders_to_consider_in_the_d/?report=objectonly" target="object" rid-figpopup="figcanavanTdisorderstoconsiderinthed" rid-ob="figobcanavanTdisorderstoconsiderinthed">c.433-2A&#x0003e;G</a> <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variant &#x02013; not a typical <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> variant &#x02013; has been found in a single Ashkenazi Jewish family; more than 70 additional pathogenic variants have been reported in non-Ashkenazi Jewish populations [<a class="bk_pop" href="#canavan.REF.kaul.1994b.34">Kaul et al 1994b</a>, <a class="bk_pop" href="#canavan.REF.elpeleg.1999.531">Elpeleg &#x00026; Shaag 1999</a>, <a class="bk_pop" href="#canavan.REF.olsen.2002.e55">Olsen et al 2002</a>, <a class="bk_pop" href="#canavan.REF.zeng.2002.557">Zeng et al 2002</a>, <a class="bk_pop" href="#canavan.REF.michals.2011">Michals &#x00026; Matalon 2011</a>]. Large deletions have also been reported [<a class="bk_pop" href="#canavan.REF.zeng.2006.156">Zeng et al 2006</a>, <a class="bk_pop" href="#canavan.REF.kaya.2008.675">Kaya et al 2008</a>]. The authors encountered two individuals with complete <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>ASPA</i> and two with partial deletions [Matalon, unpublished data].</p><div id="canavan.T.selected_aspa_pathogenic_varia" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Selected <i>ASPA</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1234/table/canavan.T.selected_aspa_pathogenic_varia/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__canavan.T.selected_aspa_pathogenic_varia_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_canavan.T.selected_aspa_pathogenic_varia_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_canavan.T.selected_aspa_pathogenic_varia_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_canavan.T.selected_aspa_pathogenic_varia_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_canavan.T.selected_aspa_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.212G&#x0003e;A</td><td headers="hd_h_canavan.T.selected_aspa_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg71His</td><td headers="hd_h_canavan.T.selected_aspa_pathogenic_varia_1_1_1_3" rowspan="7" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?val=NM_000049.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000049<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/entrez/viewer.fcgi?val=NP_000040.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000040<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_canavan.T.selected_aspa_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.433-2A&#x0003e;G</td><td headers="hd_h_canavan.T.selected_aspa_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_canavan.T.selected_aspa_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.693C&#x0003e;A</td><td headers="hd_h_canavan.T.selected_aspa_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr231Ter</td></tr><tr><td headers="hd_h_canavan.T.selected_aspa_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.770C&#x0003e;G</td><td headers="hd_h_canavan.T.selected_aspa_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro257Arg</td></tr><tr><td headers="hd_h_canavan.T.selected_aspa_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.854A&#x0003e;C</td><td headers="hd_h_canavan.T.selected_aspa_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu285Ala</td></tr><tr><td headers="hd_h_canavan.T.selected_aspa_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.863A&#x0003e;G</td><td headers="hd_h_canavan.T.selected_aspa_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr288Cys</td></tr><tr><td headers="hd_h_canavan.T.selected_aspa_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.914C&#x0003e;A</td><td headers="hd_h_canavan.T.selected_aspa_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala305Glu</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>ASPA</i> encodes aspartoacylase, a protein of 313 amino acids, suggesting a molecular weight of 36 kd [<a class="bk_pop" href="#canavan.REF.kaul.1993.118">Kaul et al 1993</a>]. Aspartoacylase catalyzes the conversion of N-acetyl_L-aspartic acid (NAA) to aspartate and acetate. The protein has a high degree of conservation across mammals [<a class="bk_pop" href="#canavan.REF.kaul.1994a.364">Kaul et al 1994a</a>].</p><p>Aspartoacylase is observed in most tissues. NAA is abundant in the brain, where hydrolysis by aspartoacylase is thought to help maintain white matter. This protein is an NAA scavenger in other tissues.</p><p>The protein forms a dimer with zinc at the catalytic site analogous to other carboxypeptidases. Aspartoacylase is responsible for hydrolyzing N-acetylaspartic acid (NAA) into aspartic acid and acetate.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Loss or reduction of aspartoacylase activity causes Canavan disease. Some pathogenic variants caused conformational changes that affect the activity of the enzyme [<a class="bk_pop" href="#canavan.REF.bitto.2007.456">Bitto et al 2007</a>]. Although aspartoacylase is expressed widely throughout the body, its absence in the CNS leads to the specific buildup of NAA in the brain that causes demyelinization and other signs of the disease.</p></div><div id="canavan.References"><h2 id="_canavan_References_">References</h2><div id="canavan.Published_Guidelines__Consensus"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="canavan.REF1">American College of Medical Genetics. Position statement on carrier testing for Canavan disease. 1998.</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.acog_committee_on_genetics.1999.91">ACOG Committee on Genetics.  ACOG committee opinion. Screening for Canavan disease. Number 212, November 1998. Committee on Genetics. American College of Obstetricians and Gynecologists. <span><span class="ref-journal">Int J Gynaecol Obstet. </span>1999;<span class="ref-vol">65</span>:91–2.</span> [<a href="/pubmed/10390111" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10390111</span></a>]</div></li></ul></div><div id="canavan.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.acog_committee_on_genetics.2009.950">ACOG Committee on Genetics.  ACOG committee opinion. Number 442, October. Prenatal and preconceptional carrier screening for genetic diseases in individuals of Eastern European Jewish descent. <span><span class="ref-journal">Obstet Gynecol. </span>2009;<span class="ref-vol">114</span>:950–3.</span> [<a href="/pubmed/19888064" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19888064</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.bitto.2007.456">Bitto E, Bingman CA, Wesenberg GE, McCoy JG, Phillips GN Jr. Structure of aspartoacylase, the brain enzyme impaired in Canavan disease. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2007;<span class="ref-vol">104</span>:456–61.</span> [<a href="/pmc/articles/PMC1766406/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1766406</span></a>] [<a href="/pubmed/17194761" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17194761</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.caliebe.2010.184">Caliebe A, Vater I, Plendl H, Gesk S, Siebert R, Cremer FW, Klein-Hitpass L. A. 439 kb-sized homozygous deletion in 17p13.3 leading to biallelic loss of the ASPA as cause of Canavan disease detected by SNP-array analysis. <span><span class="ref-journal">Mol Genet Metab. </span>2010;<span class="ref-vol">99</span>:184–5.</span> [<a href="/pubmed/19932039" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19932039</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.cozzolino.2011.706">Cozzolino M, Augello B, Carella M, Palumbo O, Tavazzi B, Amorini AM, Lazzarino G, Merla G, Brunetti-Pierri N. Chromosomal 17p13.3 microdeletion unmasking recessive Canavan disease mutation. <span><span class="ref-journal">Mol Genet Metab. </span>2011;<span class="ref-vol">104</span>:706–7.</span> [<a href="/pubmed/22019069" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22019069</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.delaney.2015.218">Delaney KE, Kralik SF, Hainline BE, Golomb MR. An atypical case of Canavan disease with stroke-like presentation. <span><span class="ref-journal">Pediatr Neurol. </span>2015;<span class="ref-vol">52</span>:218–21.</span> [<a href="/pubmed/25497124" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25497124</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.elpeleg.1999.531">Elpeleg ON, Shaag A. The spectrum of mutations of the aspartoacylase gene in Canavan disease in non-Jewish patients. <span><span class="ref-journal">J Inherit Metab Dis. </span>1999;<span class="ref-vol">22</span>:531–4.</span> [<a href="/pubmed/10407784" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10407784</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.fares.2008.236">Fares F, Badarneh K, Abosaleh M, Harari-Shaham A, Diukman R, David M. Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated? <span><span class="ref-journal">Prenat Diagn. </span>2008;<span class="ref-vol">28</span>:236–41.</span> [<a href="/pubmed/18264947" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18264947</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.karimzadeh.2014.66">Karimzadeh P, Jafari N, Nejad Biglari H, et al.  The clinical features and diagnosis of Canavan&#x02019;s disease: A case series of Iranian patients. <span><span class="ref-journal">Iran J Child Neurol. </span>2014;<span class="ref-vol">8</span>:66–71.</span> [<a href="/pmc/articles/PMC4307371/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4307371</span></a>] [<a href="/pubmed/25657773" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25657773</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.kaul.1994a.364">Kaul R, Balamurugan K, Gao GP, Matalon R. Canavan disease: genomic organization and localization of human ASPA to 17p13-ter and conservation of the ASPA gene during evolution. <span><span class="ref-journal">Genomics. </span>1994a;<span class="ref-vol">21</span>:364–70.</span> [<a href="/pubmed/8088831" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8088831</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.kaul.1994b.34">Kaul R, Gao GP, Aloya M, Balamurugan K, Petrosky A, Michals K, Matalon R. Canavan disease: mutations among Jewish and non-jewish patients. <span><span class="ref-journal">Am J Hum Genet. </span>1994b;<span class="ref-vol">55</span>:34–41.</span> [<a href="/pmc/articles/PMC1918221/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1918221</span></a>] [<a href="/pubmed/8023850" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8023850</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.kaul.1993.118">Kaul R, Gao GP, Balamurugan K, Matalon R. Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease. <span><span class="ref-journal">Nat Genet. </span>1993;<span class="ref-vol">5</span>:118–23.</span> [<a href="/pubmed/8252036" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8252036</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.kaya.2008.675">Kaya N, Imtiaz F, Colak D, Al-Sayed M, Al-Odaib A, Al-Zahrani F, Al-Mubarak BR, Al-Owain M, Al-Dhalaan H, Chedrawi A, Al-Hassnan Z, Coskun S, Sakati N, Ozand P, Meyer BF. Genome-wide gene expression profiling and mutation analysis of Saudi patients with Canavan disease. <span><span class="ref-journal">Genet Med. </span>2008;<span class="ref-vol">10</span>:675–84.</span> [<a href="/pubmed/18978679" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18978679</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.kronn.1995.1250">Kronn D, Oddoux C, Phillips J, Ostrer H. Prevalence of Canavan disease heterozygotes in the New York metropolitan Ashkenazi Jewish population. <span><span class="ref-journal">Am J Hum Genet. </span>1995;<span class="ref-vol">57</span>:1250–2.</span> [letter] [<a href="/pmc/articles/PMC1801394/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1801394</span></a>] [<a href="/pubmed/7485179" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7485179</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.kurczynski.2011">Kurczynski TW, Victorio MC. Atypical Canavan disease associated with a p.A305E mutation and a p.P257R novel variant in the aspartoacylase gene. Abstract 312. Vancouver, Canada: American College of Medical Genetics Annual Clinical Genetics Meeting; 2011.</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.matalon.1993.744">Matalon R, Kaul R, Michals K. Canavan disease: biochemical and molecular studies. <span><span class="ref-journal">J Inherit Metab Dis. </span>1993;<span class="ref-vol">16</span>:744–52.</span> [<a href="/pubmed/8412017" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8412017</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.matalon.1995.511">Matalon R, Michals K, Kaul R. Canavan disease: from spongy degeneration to molecular analysis. <span><span class="ref-journal">J Pediatr. </span>1995;<span class="ref-vol">127</span>:511–7.</span> [<a href="/pubmed/7562269" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7562269</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.matalon.2015">Matalon R, Michals Matalon K. Canavan disease. In: Rosenberg RN, Pascual JM, eds. <em>Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease</em>. 5 ed. Academic Press; 2015:695-701.</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.matalon.1998.69">Matalon R, Michals-Matalon K. Molecular basis of Canavan disease. <span><span class="ref-journal">Eur J Paediatr Neurol. </span>1998;<span class="ref-vol">2</span>:69–76.</span> [<a href="/pubmed/10724099" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10724099</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.matalon.2000.d307">Matalon RM, Michals-Matalon K. Spongy degeneration of the brain, Canavan disease: biochemical and molecular findings. <span><span class="ref-journal">Front Biosci. </span>2000;<span class="ref-vol">5</span>:D307–11.</span> [<a href="/pubmed/10704428" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10704428</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.michals.2011">Michals K, Matalon R. Canavan disease. In: Raymond GV, Eichler F, Fatemi A, Naidu S, eds. <em>Leukodystrophies</em>. London: Mac Keith Press; 2011:156-69.</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.olsen.2002.e55">Olsen TR, Tranebjaerg L, Kvittingen EA, Hagenfeldt L, Moller C, Nilssen O. Two novel aspartoacylase gene (ASPA) missense mutations specific to Norwegian and Swedish patients with Canavan disease. <span><span class="ref-journal">J Med Genet. </span>2002;<span class="ref-vol">39</span>:e55.</span> [<a href="/pmc/articles/PMC1735245/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735245</span></a>] [<a href="/pubmed/12205125" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12205125</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.shaag.1995.572">Shaag A, Anikster Y, Christensen E, Glustein JZ, Fois A, Michelakakis H, Nigro F, Pronicka E, Ribes A, Zabot MT, et al.  The molecular basis of canavan (aspartoacylase deficiency) disease in European non-Jewish patients. <span><span class="ref-journal">Am J Hum Genet. </span>1995;<span class="ref-vol">57</span>:572–80.</span> [<a href="/pmc/articles/PMC1801272/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1801272</span></a>] [<a href="/pubmed/7668285" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7668285</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.surendran.2003.809">Surendran S, Bamforth FJ, Chan A, Tyring SK, Goodman SI, Matalon R. Mild elevation of N-acetylaspartic acid and macrocephaly: diagnostic problem. <span><span class="ref-journal">J Child Neurol. </span>2003;<span class="ref-vol">18</span>:809–12.</span> [<a href="/pubmed/14696913" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14696913</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.tacke.2005.252">Tacke U, Olbrich H, Sass JO, Fekete A, Horvath J, Ziyeh S, Kleijer WJ, Rolland MO, Fisher S, Payne S, Vargiami E, Zafeiriou DI, Omran H. Possible genotype-phenotype correlations in children with mild clinical course of Canavan disease. <span><span class="ref-journal">Neuropediatrics. </span>2005;<span class="ref-vol">36</span>:252–5.</span> [<a href="/pubmed/16138249" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16138249</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.yalcinkaya.2005.336">Yalcinkaya C, Benbir G, Salomons GS, Karaarslan E, Rolland MO, Jakobs C, van der Knaap MS. Atypical MRI findings in Canavan disease: a patient with a mild course. <span><span class="ref-journal">Neuropediatrics. </span>2005;<span class="ref-vol">36</span>:336–9.</span> [<a href="/pubmed/16217711" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16217711</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.zeng.2002.557">Zeng BJ, Wang ZH, Ribeiro LA, Leone P, De Gasperi R, Kim SJ, Raghavan S, Ong E, Pastores GM, Kolodny EH. Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease. <span><span class="ref-journal">J Inherit Metab Dis. </span>2002;<span class="ref-vol">25</span>:557–70.</span> [<a href="/pubmed/12638939" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12638939</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="canavan.REF.zeng.2006.156">Zeng BJ, Wang ZH, Torres PA, Pastores GM, Leone P, Raghavan SS, Kolodny EH. Rapid detection of three large novel deletion of the aspartoacylase gene in non-jewish patients with Canavan disease. <span><span class="ref-journal">Mol Genet Metab. </span>2006;<span class="ref-vol">89</span>:156–63.</span> [<a href="/pubmed/16854607" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16854607</span></a>]</div></li></ul></div></div><div id="canavan.Chapter_Notes"><h2 id="_canavan_Chapter_Notes_">Chapter Notes</h2><p><b>Author History</b></p><p>Gita Bhatia, PhD; University of Texas Medical Branch (2009-2011)<br />Kimberlee Michals-Matalon, PhD, RD (2011-present)<br />Reuben Matalon, PhD (1999-present)<br />Lisvania Delgado, BS (2018-present)</p><div id="canavan.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>13 September 2018 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>11 August 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>1 October 2009 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>15 March 2006 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> clinically available</div></li><li class="half_rhythm"><div>30 December 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>7 November 2003 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>3 October 2001 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>16 September 1999 (pb) Review posted live</div></li><li class="half_rhythm"><div>17 April 1999 (rm) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1234</span><span class="label">PMID: <a href="/pubmed/20301412" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301412</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ced/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cantu/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1234&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1234/?report=reader">PubReader</a></li><li><a href="/books/NBK1234/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1234" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1234" style="display:none" title="Cite this Page"><div class="bk_tt">Matalon R, Delgado L, Michals-Matalon K. Canavan Disease. 1999 Sep 16 [Updated 2018 Sep 13]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1234/pdf/Bookshelf_NBK1234.pdf">PDF version of this page</a> (438K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#canavan.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#canavan.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#canavan.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#canavan.Genetically_Related_Allelic_Diso" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#canavan.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#canavan.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#canavan.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#canavan.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#canavan.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#canavan.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#canavan.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=443[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ASPA</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1479894" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1479894" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1479894" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1479894" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301691" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Classic Galactosemia and Clinical Variant Galactosemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Classic Galactosemia and Clinical Variant Galactosemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Berry GT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301397" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hexosaminidase A Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hexosaminidase A Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kaback MM, Desnick RJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301309" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Arylsulfatase A Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Arylsulfatase A Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gomez-Ospina N. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301416" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Krabbe Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Krabbe Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Orsini JJ, Escolar ML, Wasserstein MP, Caggana M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27891836" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> CLPB Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> CLPB Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wortmann SB, Wevers RA, de Brouwer APM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301412" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301412" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040ca339a66ee2ba4cff1c">Canavan Disease - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Canavan Disease - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:28:03-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8A406BE0409161000000000170007E&amp;ncbi_session=CE8A406BE040CA31_0368SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1234%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1234&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1234/&amp;ncbi_pagename=Canavan Disease - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8A406BE040CA31_0368SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>